Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High altitude-a Multicenter, Prospective Cohort Study

NCT05063643 is registered in ClinicalTrials.gov with Affiliated Hospital of Qinghai University as lead sponsor.

NCT NCT05063643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05063643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High altitude-a Multicenter, Prospective Cohort Study
Lead sponsor
Affiliated Hospital of Qinghai University
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2021
Completion date
December 31, 2024
Enrollment
132 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac toxicity, her2-positive breast cancer, high altitude, targeted therapy